Sagliker Syndrome in a Patient With Secondary Hyperparathyroidism and Chronic Kidney Disease: A Case Report From Palestine

被引:1
|
作者
Ahmad, Ibtihal [1 ]
Alkomi, Sala [1 ]
Sharaha, Rula [1 ]
Manasrah, Shaheera [1 ]
Dukmak, Osama N. [2 ]
机构
[1] Palestine Polytech Univ, Sch Med, Nephrol, Internal Med, Hebron, Palestine
[2] Al Quds Univ, Sch Med, Nephrol, Internal Med, Jerusalem, Palestine
关键词
case report; secondary hyperparathyroidism; renal osteodystrophy; chronic kidney disease; sagliker syndrome; HUMAN FACE APPEARANCE; TOTAL PARATHYROIDECTOMY; GENE;
D O I
10.7759/cureus.51956
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sagliker syndrome (SS) is a rare complication in patients with chronic kidney disease (CKD) on prolonged dialysis due to uncontrolled secondary hyperparathyroidism (SHPT). SS manifests with a constellation of clinical manifestations, including short stature, craniomaxillofacial abnormalities, hearing loss, and neuropsychiatric disorders. This article reports a 33-year-old male patient with CKD who complained of progressive disfiguring facial changes, multiple recurrent fractures, and shortened height. The condition affects his quality of life. On workup, his lab results showed highly elevated serum levels of parathyroid hormone, alkaline phosphatase (ALP), calcium, and phosphate. His comorbidities and poor health status limit his ability to do parathyroidectomy (Ptx). A reliable diagnostic approach must be considered, enabling physicians to make earlier interventions and get better outcomes.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients
    Strippoli, G. F. M.
    Tong, A.
    Palmer, S. C.
    Elder, G.
    Craig, J. C.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (04):
  • [22] Controversies in the Management of Secondary Hyperparathyroidism in Chronic Kidney Disease
    Ezequiel Bellorin-Font
    George Vasquez-Rios
    Kevin J. Martin
    Current Osteoporosis Reports, 2019, 17 : 333 - 342
  • [23] Secondary hyperparathyroidism and target organs in chronic kidney disease
    Nikodimopoulou, M.
    Liakos, S.
    HIPPOKRATIA, 2011, 15 : 33 - 38
  • [24] Controversies in the Management of Secondary Hyperparathyroidism in Chronic Kidney Disease
    Bellorin-Font, Ezequiel
    Vasquez-Rios, George
    Martin, Kevin J.
    CURRENT OSTEOPOROSIS REPORTS, 2019, 17 (05) : 333 - 342
  • [25] Secondary Hyperparathyroidism in Chronic Kidney Disease: Pathophysiology and Management
    Habas, Elmukhtar, Sr.
    Eledrisi, Mohsen
    Khan, Fahmi
    Elzouki, Abdel-Naser Y.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (07)
  • [26] Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients
    Ballinger, Angela E.
    Palmer, Suetonia C.
    Nistor, Ionut
    Craig, Jonathan C.
    Strippoli, Giovanni F. M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (12):
  • [27] Secondary hyperparathyroidism among Nigerians with chronic kidney disease
    Gimba, Zumnan M.
    Abene, Esala E.
    Agbaji, Oche O.
    Agaba, Emmanuel, I
    AFRICAN HEALTH SCIENCES, 2018, 18 (02) : 446 - 457
  • [29] Severe Secondary Hyperparathyroidism in a Hemodialysis Patient: A Case Report from Mongolia
    Adiya, Saruultuvshin
    Damdinsuren, Khurtsbayar
    Dorj, Chuluuntsetseg
    BLOOD PURIFICATION, 2017, 44 : 35 - 40
  • [30] Prognosis of Sagliker syndrome after PTX in hemodialysis patients with severe secondary hyperparathyroidism
    Zhang, Ling
    Yao, Li
    Bian, Wei-Jing
    Li, Wen-Ge
    Chen, Yi-Pu
    NEPHROLOGY, 2008, 13 : A57 - A57